The hypothetical protein Cpn1027 was detected in the inclusion membrane of Chlamydia pneumoniae-infected cells with antibodies raised with Cpn1027 fusion proteins in an indirect immunofluorescence assay. The inclusion membrane staining by the anti-Cpn1027 antibodies co-localized with the staining of an antibody recognizing a known inclusion membrane protein designated IncA and these membrane stainings were blocked by the corresponding but not irrelevant fusion proteins. Although Cpn1027 was not predicted to be an inclusion membrane protein, it contained a bi-lobed hydrophobic domain region at its N-terminus, a signature secondary structural motif possessed by most chlamydial inclusion membrane proteins. The Cpn1027 protein was detected as early as 12 h after C. pneumoniae infection and remained in the inclusion membrane throughout the rest of the infection cycle. Cytosolic expression of Cpn1027 via a transgene failed to affect the subsequent chlamydial infection. The anti-Cpn1027 polyclonal antisera failed to detect any significant signals in cells infected with chlamydial species other than C. pneumoniae, which is consistent with the sequence analysis result that no significant homologues of Cpn1027 were found in any other species. These experiments together have demonstrated that Cpn1027 is a newly identified inclusion membrane protein unique to C. pneumoniae.
AlzhanovD., BarnesJ., HrubyD. E.,
RockeyD. D.2004; Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA . BMC Microbiol 4:24[CrossRef]
BannantineJ. P., RockeyD. D.,
HackstadtT.1998; Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol Microbiol 28:1017–1026[CrossRef]
BannantineJ. P., GriffithsR. S., ViratyosinW., BrownW. J.,
RockeyD. D.2000; A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol 2:35–47[CrossRef]
CampbellL. A., NosakaT., RosenfeldM. E., YaraeiK.,
KuoC. C.2005; Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Infect Immun 73:3164–3165[CrossRef]
CarabeoR. A., MeadD. J.,
HackstadtT.2003; Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci U S A 100:6771–6776[CrossRef]
ChenC., ChenD., SharmaJ., ChengW., ZhongY., LiuK., JensenJ., ShainR., ArulanandamB.,
ZhongG.2006; The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis . Infect Immun 74:4826–4840[CrossRef]
DelevoyeC., NilgesM., Dautry-VarsatA.,
SubtilA.2004; Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae : oligomerization of IncA mediates interaction between facing membranes. J Biol Chem 279:46896–46906[CrossRef]
DongF., ZhongY., ArulanandamB.,
ZhongG.2005; Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect Immun 73:1868–1872[CrossRef]
FanP., DongF., HuangY.,
ZhongG.2002; Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression. Infect Immun 70:345–349[CrossRef]
FanT., LuH., HuH., ShiL., McClartyG. A., NanceD. M., GreenbergA. H.,
ZhongG.1998; Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187:487–496[CrossRef]
FlingS. P., SutherlandR. A., SteeleL. N., HessB., D'OrazioS. E., MaisonneuveJ., LampeM. F., ProbstP.,
StarnbachM. N.2001; CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis . Proc Natl Acad Sci U S A 98:1160–1165[CrossRef]
HackstadtT., ScidmoreM. A.,
RockeyD. D.1995; Lipid metabolism in Chlamydia trachomatis -infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92:4877–4881[CrossRef]
HackstadtT., RockeyD. D., HeinzenR. A.,
ScidmoreM. A.1996; Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J 15:964–977
HackstadtT., FischerE. R., ScidmoreM. A., RockeyD. D.,
HeinzenR. A.1997; Origins and functions of the chlamydial inclusion. Trends Microbiol 5:288–293[CrossRef]
HackstadtT., Scidmore-CarlsonM. A., ShawE. I.,
FischerE. R.1999; The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1:119–130[CrossRef]
HuH., PierceG. N.,
ZhongG.1999; The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae . J Clin Invest 103:747–753[CrossRef]
KalmanS., MitchellW., MaratheR., LammelC., FanJ., HymanR. W., OlingerL., GrimwoodJ., DavisR. W.,
StephensR. S.1999; Comparative genomes of Chlamydia pneumoniae and C. trachomatis . Nat Genet 21:385–389[CrossRef]
KuoC. C., GraystonJ. T., CampbellL. A., GooY. A., WisslerR. W.,
BendittE. P.1995a; Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old. Proc Natl Acad Sci U S A 92:6911–6914[CrossRef]
LiuL., HuH., JiH., MurdinA. D., PierceG. N.,
ZhongG.2000; Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR−/− mouse model within six months. Mol Cell Biochem 215:123–128[CrossRef]
ReadT. D., BrunhamR. C., ShenC., GillS. R., HeidelbergJ. F., WhiteO., HickeyE. K., PetersonJ., UtterbackT.other authors2000; Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28:1397–1406[CrossRef]
RockeyD. D., HeinzenR. A.,
HackstadtT.1995; Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol 15:617–626
ScidmoreM. A., FischerE. R.,
HackstadtT.1996; Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 134:363–374[CrossRef]
SharmaJ., DongF., PirbhaiM.,
ZhongG.2005; Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis . Infect Immun 73:4414–4419[CrossRef]
SharmaJ., ZhongY., DongF., PiperJ. M., WangG.,
ZhongG.2006; Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 74:1490–1499[CrossRef]
SuH., McClartyG., DongF., HatchG. M., PanZ. K.,
ZhongG.2004; Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 279:9409–9416[CrossRef]
SubtilA., ParsotC.,
Dautry-VarsatA.2001; Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 39:792–800[CrossRef]
SubtilA., DelevoyeC., BalanaM. E., TastevinL., PerrinetS.,
Dautry-VarsatA.2005; A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56:1636–1647[CrossRef]
TohH., MiuraK., ShiraiM.,
HattoriM.2003; In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae. DNA Res 10:9–17[CrossRef]
VandahlB. B., StensballeA., RoepstorffP., ChristiansenG.,
BirkelundS.2005; Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol 7:825–836[CrossRef]
XiaoY., ZhongY., GreeneW., DongF.,
ZhongG.2004; Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 72:5470–5474[CrossRef]
XiaoY., ZhongY., SuH., ZhouZ., ChiaoP.,
ZhongG.2005; NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol 174:1701–1708[CrossRef]
ZhongG., BerryJ.,
BrunhamR. C.1994; Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis . Infect Immun 62:1576–1583
ZhongG., GermainR. N., Reis e SousaC.1997; Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A 94:13856–13861[CrossRef]
ZhongG., FanP., JiH., DongF.,
HuangY.2001; Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193:935–942[CrossRef]